Egyptian Rheumatologist

Aims & Scope

The Egyptian Rheumatologist is the official journal of the Egyptian Society of Rheumatic Diseases.

The journal is published quarterly.

It publishes original papers within the various fields of rheumatology.

Articles in the field of physical medicine and rehabilitation will be accepted on condition that they are related to rheumatic and connective tissue diseases.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1
2024	1.00

Journal Rank

Year	Value
2024	15207

Journal Citation Indicator

Year	Value
2024	230

SJR (SCImago Journal Rank)

Year	Value
2024	0.348

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	24

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: Randomized clinical trial

  Citation: 92

  Authors: Aziza Sayed, Maha Emad, Amal Sayed, Mahmoud

• Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity

  Citation: 60

  Authors: Hanan M., Manal S., Rasha A., Hossam A.

• Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients

  Citation: 46

  Authors: Amal Mohamad, Manal Aly Abdel, Alaa Mohamad, Sahar Mohyeldeen

• Juvenile and adult onset systemic lupus erythematosus outcome in Egyptian patients

  Citation: 37

  Authors: Tamer A., Samar M., Abeer M., Hussein S.

• Local injection of autologous platelet rich plasma compared to corticosteroid treatment of chronic plantar fasciitis patients: A clinical and ultrasonographic follow-up study

  Citation: 37

  Authors: Nagwa A., Marwa A., Hoda A., Hanan, Samar E., Mohammed A.

• FoxP3+T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis

  Citation: 34

  Authors: Dina S., Samah A., Rasha, Laila A, Aisha Y. Abdel, Hanaa A., Afaf Abd, Hossam M., Rehab Abdel

• Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in Rheumatoid arthritis patients

  Citation: 34

  Authors: Wafaa, Ghada S., Tamer A., Abeer, Randa

• Ultrasound-guided injection of platelet rich plasma versus corticosteroid for treatment of rotator cuff tendinopathy: Effect on shoulder pain, disability, range of motion and ultrasonographic findings

  Citation: 33

  Authors: Doaa H., Nagat M., Hanan M., Radwa M.

• Quality of life assessment in Egyptian rheumatoid arthritis patients: Relation to clinical features and disease activity

  Citation: 32

  Authors: Rania M., Safaa A., Noha, Fadwa

• Clinical significance of serum TNFα and -308 G/A promoter polymorphism and serum Il-6 and -174 G/C promoter polymorphism in systemic lupus erythematosus patients

  Citation: 31

  Authors: Ghada S., Tamer A., Wafaa, Abeer

---